Wednesday, February 01, 2006

Ayurveda drug offers hope for osteo-arthritis

DECKS have been cleared and ethical approvals taken for the final phase of the multi-centric trial to test an ayurvedic drug formulation for the treatment of osteo-arthritis (OA). This unique trial is sponsored by the Council of Scientific and Industrial Research (CSIR)s ambitious New Millennium Indian Technology Leadership Initiative (NMITLI) project.

This purely herbal ayurvedic drug formulation, which does not use metals, is being tested at four places— Centre for Rheumatic Diseases (CRD) Pune, KEM Hospital and Swami Prakash Anand Ayurved Research Centre at Mumbai, Nizamuddin Institute for Medical Sciences (NIMS) Hyderabad and All India Institute of Medical Sciences (AIIMS), New Delhi.

Post a Comment